↓ Skip to main content

Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial

Overview of attention for article published in The Lancet Gastroenterology & Hepatology, June 2023
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#8 of 1,651)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
90 news outlets
blogs
2 blogs
twitter
32 X users
facebook
2 Facebook pages
reddit
1 Redditor

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
30 Mendeley